B3 - Brasil, Bolsa, Balcão (B3SA3) Q1 2025 earnings summary

Executive summary

• Total revenues reached R$2.7 billion in 1Q25, up 7.7% year-over-year, driven by growth in Derivatives, Fixed Income and Credit, and Securities Lending, offsetting a decline in Equities revenues.

• Net income rose 16.5% to R$1.1 billion, with EPS up 24.5% to R$0.21, reflecting share buybacks.

• Recurring EBITDA grew 5.5% to R$1,660.2 million year-over-year, with margin at 69.5%.

• New revenue segmentation was implemented to align with strategic growth areas.

• Incorporation of Neoway and Neurotech approved, optimizing structure and enabling tax benefits.

Financial highlights

• Net revenues were R$2,388.0 million, up 7.5% year-over-year.

• Expenses fell 10.6% to R$828.5 million, mainly due to the end of Cetip-related amortization; adjusted expenses rose 8.5%.

• Financial result was R$15.6 million, down 65.6% year-over-year, impacted by FX and higher debt.

• Shareholder distributions totaled R$786.5 million, including R$459.0 million in buybacks and R$327.5 million in interest on capital.

• Gross debt at R$14.9 billion, 2.2x LTM recurring EBITDA; cash and equivalents at R$17.1 billion.

Outlook and guidance

• Management highlights ongoing strategy to diversify revenues and expand in adjacent areas.

• New product launches in indices options and fixed income indices to drive future growth.

• Ongoing focus on technology upgrades and efficiency in project management for 2025.

• Expense growth is expected to remain within guidance, despite inflationary pressures and higher salary adjustments.

• Management sees more upside than downside risk for trading volumes, with recent months showing stabilization and potential for growth.